These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 20698241)

  • 1. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
    Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
    Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive IPMN and MCN: same organ, different outcomes?
    Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
    Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
    Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T
    J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
    Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB
    Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.
    Fujii T; Kato K; Kodera Y; Kanda M; Nagai S; Yamada S; Kanzaki A; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakamura S; Nakao A
    Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with the postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas.
    Park J; Lee KT; Jang TH; Seo YW; Lee KH; Lee JK; Jang KT; Heo JS; Choi SH; Choi DW; Rhee JC
    Pancreas; 2011 Jan; 40(1):46-51. PubMed ID: 21160369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical aspects of intraductal papillary mucinous neoplasm of the pancreas].
    Oláh A
    Magy Seb; 2014 Apr; 67(2):39-43. PubMed ID: 24747402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas.
    Eguchi H; Ishikawa O; Ohigashi H; Sasaki Y; Yamada T; Nakaizumi A; Uehara H; Takenaka A; Kasugai T; Imaoka S
    Cancer; 2006 Dec; 107(11):2567-75. PubMed ID: 17054109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent invasive intraductal papillary mucinous carcinoma of the pancreas mimicking pott disease: review of the literature.
    Corvera CU; Dunnican WJ; Blumgart LH; D'Angelica M
    Pancreas; 2006 Apr; 32(3):321-4. PubMed ID: 16628089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.
    Passot G; Lebeau R; Hervieu V; Ponchon T; Pilleul F; Adham M
    Pancreas; 2012 Jan; 41(1):137-41. PubMed ID: 22076564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.